This inventor holds 1 USPTO granted patent. Top assignees: Intellia Therapeutics, Inc., Novartis Ag. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 20 
1 out of 3,978 
Years Active: 2023
Title: Innovations of Hyungwook Lim in Immuno-Oncology
Introduction
Hyungwook Lim is a notable inventor based in Newton, MA, who has made significant contributions to the field of immuno-oncology. His work focuses on genome editing systems and methods that aim to enhance cancer treatment. With one patent to his name, Lim's innovations are paving the way for advancements in medical science.
Latest Patents
Hyungwook Lim holds a patent titled "Compositions and methods for immunooncology." This patent is directed towards genome editing systems, reagents, and methods that are crucial for immuno-oncology applications. His research is instrumental in developing new therapeutic strategies for cancer treatment.
Career Highlights
Throughout his career, Lim has worked with prominent companies in the biotechnology sector. He has been associated with Novartis AG and Intellia Therapeutics, Inc., where he has contributed to groundbreaking research and development efforts. His experience in these organizations has enriched his expertise in the field.
Collaborations
Lim has collaborated with notable colleagues, including Jennifer Brogdon and Ming-Wei Chen. These partnerships have fostered a collaborative environment that enhances innovation and research in immuno-oncology.
Conclusion
Hyungwook Lim's contributions to immuno-oncology through his patent and collaborations highlight his role as an influential inventor in the field. His work continues to inspire advancements in cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile